首页> Pharmacogenetics and genomics> PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

导出 OA

翻译打印收藏纠错

第一作者： Liudmila L,Mazaleuskaya

第一单位： aDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA.

作者： Liudmila L,Mazaleuskaya ^[1] ; Katrin,Sangkuhl ; Caroline F,Thorn ; Garret A,FitzGerald ; Russ B,Altman ; Teri E,Klein

作者单位： aDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA. ^[1]

医学主题词醋氨酚(Acetaminophen);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物相互作用(Drug Interactions);人类(Humans);代谢组学(Metabolomics);遗传药理学(Pharmacogenetics)

DOI 10.1097/FPC.0000000000000150

PMID 26049587

发布时间 2022-04-08

基金项目

R24 GM061374/GM/NIGMS NIH HHS/United States U54 HL117798/HL/NHLBI NIH HHS/United States HL117798/HL/NHLBI NIH HHS/United States T32 HL007971/HL/NHLBI NIH HHS/United States R24 GM61374/GM/NIGMS NIH HHS/United States T32HL007971/HL/NHLBI NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交